Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma.
4 affiliations
- 1Department of Pathology, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian, 350025, China.
- 2Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350004, China.
- 3Department of Pathology, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian, 350025, China; Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350004, China. Electronic address: [email protected].
- 4Department of Pathology, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian, 350025, China; Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350004, China. Electronic address: [email protected].
Abstract
This study aimed to investigate the clinical, pathological, and immune characteristics of macrotrabecular hepatocellular carcinoma (MT-HCC) to identify distinct features, evaluate prognostic significance, and explore potential therapeutic targets for MT-HCC. A total of 83 MT-HCC and 111 CV-HCC patients who underwent liver resection were included. Clinicopathological data were analyzed using statistical methods. Among these cases, immunohistochemical (IHC) staining was performed on 48 cases of massive trabecular hepatocellular carcinoma to evaluate the distribution of immune cells across different tumor regions. The Friedman test, Spearman's correlation analysis, Kaplan-Meier survival analysis, and Cox regression analysis were used to examine the relationships between immune infiltration characteristics and prognosis. MT-HCC exhibited more aggressive features, such as higher serum AFP levels (68% vs. 21%, p < 0.001), larger tumor size (7.65 cm vs. 4.47 cm, p < 0.001), and a higher frequency of vascular invasion (22% vs. 4%, p < 0.001), satellite nodules (41%vs. 16%, p < 0.001), and tumor necrosis (84% vs. 47%, p < 0.001). Survival analysis showed worse overall survival and higher recurrence rates in MT-HCC. The immune microenvironment displayed a typical "immune desert" phenotype, characterized by the spatial distribution of adaptive immune cells: sparse distribution within the tumor, enrichment at tumor margins, and enrichment adjacent to the tumor. In MT‑HCC, PD‑L1 expression was extremely low across all three tumor regions, whereas CTLA‑4 showed specific high expression at the tumor margins. Intratumoral CD8⁺ T cells exhibited a significant positive correlation with PD‑1 and CTLA‑4 (r = 0.701, P < 0.001), suggesting the dual exhaustion state of intratumoral T cells. Multivariate analysis identified cross‑regional FOXP3⁺ Treg infiltration, maximum tumor diameter, and macrovascular invasion as independent risk factors for overall survival. Conversely, peritumoral CD4⁺ T cells served as protective immune markers and were associated with reduced mortality risk in patients. The findings suggest that MT-HCC possesses invasive clinical characteristics and exhibits distinctive spatial immune heterogeneity, where immune cell distribution plays a critical role in prognosis. Targeting specific immune cell populations may offer new therapeutic strategies for MT-HCC and improve patient outcomes.
Related
- SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features.
- Network perturbation of lactate metabolism identifies an aggressive hepatocellular carcinoma subtype with distinct immune and microbial features.
- Potential Influence of NUCB2 Genetic Variants on the Clinicopathological Features of Patients with Hepatocellular Carcinoma
- Associations of fasting blood glucose and the triglyceride–glucose index with aggressive pathological features of papillary thyroid carcinoma
- Construction of a liver hepatocellular carcinoma risk model based on fumarate metabolism-associated genes to predict prognosis and immunological landscape.
BibTeX
@article{wu2026aggressive,
title = {{Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma.}},
author = {Lixia Wu and Meidan Li and Xuefang Wang and Qionglan Wu and Yi Chen and Bin Wang and Lihong Chen},
journal = {Translational oncology},
year = {2026},
month = oct,
doi = {10.1016/j.tranon.2026.103075},
url = {https://europepmc.org/article/MED/42868716},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma.
AU - Lixia Wu
AU - Meidan Li
AU - Xuefang Wang
AU - Qionglan Wu
AU - Yi Chen
AU - Bin Wang
AU - Lihong Chen
PY - 2026
DA - 2026/10/13
JO - Translational oncology
DO - 10.1016/j.tranon.2026.103075
UR - https://europepmc.org/article/MED/42868716
AB - This study aimed to investigate the clinical, pathological, and immune characteristics of macrotrabecular hepatocellular carcinoma (MT-HCC) to identify distinct features, evaluate prognostic significance, and explore potential therapeutic targets for MT-HCC. A total of 83 MT-HCC and 111 CV-HCC patients who underwent liver resection were included. Clinicopathological data were analyzed using statistical methods. Among these cases, immunohistochemical (IHC) staining was performed on 48 cases of massive trabecular hepatocellular carcinoma to evaluate the distribution of immune cells across different tumor regions. The Friedman test, Spearman's correlation analysis, Kaplan-Meier survival analysis, and Cox regression analysis were used to examine the relationships between immune infiltration characteristics and prognosis. MT-HCC exhibited more aggressive features, such as higher serum AFP levels (68% vs. 21%, p < 0.001), larger tumor size (7.65 cm vs. 4.47 cm, p < 0.001), and a higher frequency of vascular invasion (22% vs. 4%, p < 0.001), satellite nodules (41%vs. 16%, p < 0.001), and tumor necrosis (84% vs. 47%, p < 0.001). Survival analysis showed worse overall survival and higher recurrence rates in MT-HCC. The immune microenvironment displayed a typical "immune desert" phenotype, characterized by the spatial distribution of adaptive immune cells: sparse distribution within the tumor, enrichment at tumor margins, and enrichment adjacent to the tumor. In MT‑HCC, PD‑L1 expression was extremely low across all three tumor regions, whereas CTLA‑4 showed specific high expression at the tumor margins. Intratumoral CD8⁺ T cells exhibited a significant positive correlation with PD‑1 and CTLA‑4 (r = 0.701, P < 0.001), suggesting the dual exhaustion state of intratumoral T cells. Multivariate analysis identified cross‑regional FOXP3⁺ Treg infiltration, maximum tumor diameter, and macrovascular invasion as independent risk factors for overall survival. Conversely, peritumoral CD4⁺ T cells served as protective immune markers and were associated with reduced mortality risk in patients. The findings suggest that MT-HCC possesses invasive clinical characteristics and exhibits distinctive spatial immune heterogeneity, where immune cell distribution plays a critical role in prognosis. Targeting specific immune cell populations may offer new therapeutic strategies for MT-HCC and improve patient outcomes.
SN - 1936-5233
ER -